hallpass-banner


reserve-banner
directions-banner
parking-banner
button-transit-banner

CAN’T MAKE THE FULL EVENT? REGISTER FOR THE WORLD PHARMA WEEK EXHIBITS & KEYNOTE PASS. REGISTER TODAY.

You will gain access to:
» Over 130 Exhibiting Companies
» Network with 1,300 Attendees - 72% Biotech & Pharma
» Access to Exhibit Hall
» Access to Plenary Keynote Sessions Tuesday, June 18 – Thursday, June 20
» Participate in 30+ Roundtable Breakout Discussions
» View over 130 Scientific Posters
» Network during Receptions and Coffee Breaks
» Poster Competitions Awards

Register-banner

Tuesday, June 18

Exhibit hall open from 9:40am – 6:35pm

9:40 – 10:25am Grand Opening Coffee Break and Poster Viewing – Commonwealth Hall

2:25 – 3:10pm Refreshment Break and Poster Viewing – Commonwealth Hall

3:10pm IO Plenary Session – Amphitheater

Join us for an IO focused Keynote Panel on Partnering Ecosystem as part of the IO Pharma Congress.

IO PLENARY SESSION: PARTNERING ECOSYSTEM

PANEL DISCUSSION: Partnering, Preclinical Strategies and Tools, IO Clinical Trials; Capital Invested in IO Relative to Other Oncology Areas

Moderator:
Leigh Zawel, PhD, CSO, Cullinan Oncology


Panelists:
Michael Woo, Director, Head of Immuno-Oncology Search & Evaluation, External Innovation, EMD Serono, Inc.


Sybil Williams, PhD, Director, Biology Oncology Discovery, Merck


Paul Young, PhD, Executive Director, Business Development & Licensing, Merck


Jernej Godec, PhD, Associate, Apple Tree Partners


Stacey J. Adam, PhD, Director, Cancer Research Partnerships, Foundation for the National Institutes of Health



  • Has the IO bubble popped? Why have no other IO drugs emerged with PD1/PDL1-like efficacy?
  • What combination strategies are being explored to convert poorly PD1 responsive tumors to more responsive ones?
  • Are there new IO monotherapies or combos that appear promising?
  • Is patient stratification practical with IO therapies?
  • What partnering strategies are most effective?
  • What is a recent deal your firm signed that you’re excited about?

4:20 – 5:20pm Plenary Keynote Presentation - Amphitheater

TURNING SCIENCE INTO MEDICINE: The Science behind the 5R Framework

Mene Pangalos, PhD, Executive Vice-President, Research & Development, BioPharmaceuticals, AstraZeneca

Improving R&D productivity is critical to the success of drug discovery, with failure rates from pre-clinical development to launch often in excess of 90 percent. In AstraZeneca, we conducted an in-depth review of our R&D activities to help us identify ‘success factors’ that could improve the probability of success for any given drug discovery program. As a result, we launched the ‘5R framework’: right target, right tissue, right safety, right patient, and right commercial, focused on the quality of our programs rather than the quantity of programs. In the five years since inception of this 5R framework our success rates have increased almost five-fold to 19% from pre-clinical investigation to completion of Phase III clinical trials.

MINING FOR TOMORROW’S CURES: A Nex-Gen Model of Drug Development

Jennifer Michaelson, PhD, Vice President, Preclinical Research & Early Development, Cullinan Oncology

Drug development in oncology and immuno-oncology is accelerating at a record pace. The multitude of drug targeting modalities and mechanisms being pursued within big pharma and biotech is astounding. Cullinan Oncology has a unique approach to leverage the array of cutting-edge opportunities and broad range of scientific approaches within the fast moving oncology drug development space. A hybrid operating structure enables Cullinan to develop a diversified oncology portfolio of single asset opportunities across a range of mechanisms and modalities within oncology and immune-oncology. The model entails a balance of externally and internally derived programs, a cost-efficient management structure, and an outsourced model to drive speed, nimbleness, risk diversification and efficiency. Case studies exemplifying the efficiency in getting to key go/no go decisions will be presented. The ultimate goal is to develop high value oncology therapeutics that have the potential to significantly improve upon standard of care for patients.

5:20 – 6:35pm Taste of New England Welcome Reception in the Exhibit Hall with Poster Viewing – Commonwealth Hall

6:20pm Amazon Echo Raffle!* – Commonwealth Hall

6:40 – 7:30pm Interactive Breakout Discussions – Commonwealth Hall

6:25pmAfter Hours Networking at Seaport HOtel 

Wednesday, June 19

Exhibit hall open from 9:35am – 6:00pm

9:35 – 10:20am Coffee Break and Poster Viewing – Commonwealth Hall

12:50 – 2:20pm Plenary Keynote Presentation- Amphitheater

PLENARY PANEL DISCUSSION: Data Driven Drug Discovery and Development: Digital, AI and ML to Re-Shape R&D

Moderator:
Peter Henstock, PhD, AI & Machine Learning Lead, Pfizer


Panelists:
Litao Zhang, PhD, Vice President, Leads Discovery and Optimization, Bristol-Myers


Daniel Karlin, MD, Director of Biotech Ventures, CEAi, Inc


Christine Dingivan, PhD, Global Drug Development Head, Data and Digital, Novartis


Peter Bergethon, Vice President, Quantitative Medicine & Clinical Technologies, Biogen


Kim Branson, PhD, Head of AI, Early Clinical Development, Genentech, A Member of the Roche Group



This panel will ask leaders focused on drug discovery and development how they view AI/ML/Digital as an opportunity over the next 1-5 years to improve their business including:

  • In what parts of the business do they see the most opportunities and needs now?
  • How does these technologies fit within their overall strategy?
  • What is the right balance of partnering externally versus developing an internal Digital/AI team?
  • What were the challenges in kickstarting the first AI/Digital projects?

2:20 – 3:05pm Dessert and Coffee Break and Poster Viewing – Commonwealth Hall

2:55pm $300 Amazon Gift Card Raffle!* – Commonwealth Hall

5:05 – 6:00pm 4th of July Celebration (BBQ, Beer and Wine, Cornhole, Jenga, Fun!) and Poster Viewing – Commonwealth Hall

5:55pm Bose® Soundlink® Raffle!* – Commonwealth Hall

6:25pm After Hours Networking At Trillium Fort Point Brewery 

Thursday, June 20

Exhibit hall open from 10:15am – 2:20pm

7:15 - 8:10am Interactive Breakout Discussions (with Continental Breakfast) – Commonwealth Hall

10:15 – 11:00am Coffee Break and Poster Winner Announced – Commonwealth Hall

10:50am $300 Amazon Gift Card Raffle!* – Commonwealth Hall

1:35 – 2:20pm Dessert and Coffee Break and Poster Winner Announced– Commonwealth Hall

2:15pm AncestryDNA™ Raffle!* – Commonwealth Hall

* Amazon, AncestryDNA™ and Bose® are not sponsors or participants of this event. Sponsors and exhibitors not eligible. Must be present to win!

**Exhibit hours are subject to change.**

Exhibit Hall Hours

TUESDAY, JUNE 18

Exhibit hall open from 9:40am – 6:35pm

9:40 – 10:25am Grand Opening Coffee Break and Poster Viewing

2:25 – 3:10pm Refreshment Break and Poster Viewing

5:20 – 6:35pm Taste of New England Welcome Reception and Poster Viewing

6:20pm Amazon Echo Raffle!*

WEDNESDAY, JUNE 19

Exhibit hall open from 9:35am – 6:00pm

9:35 – 10:20am Coffee Break and Poster Winner Announced

2:20 – 3:05pm Dessert and Coffee Break and Poster Viewing

2:55pm $300 Amazon Gift Card Raffle!*

5:05 – 6:00pm 4th of July Celebration Reception and Poster Viewing

5:55pm Bose® Soundlink® Raffle!*

THURSDAY, JUNE 20

Exhibit hall open from 10:15am – 2:20pm

10:15 – 11:00am Coffee Break and Poster Winner Announced

10:50am $300 Amazon Gift Card Raffle!*

1:35 – 2:20pm Dessert and Coffee Break and Poster Viewing

2:15pm AncestryDNA™Raffle!*